Red Flags Detected

  • Going Concern (new) — Company discloses substantial doubt about ability to continue operations due to insufficient cash to fund planned operations for twelve months.
NASDAQ: ONCY ONCOLYTICS BIOTECH INC 10-Q

Oncolytics faces going concern warning with $5.5M cash despite FDA Fast Track win

Filed May 14, 2026 · Period ending March 31, 2026 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ONCY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 25, 2026 10:40 AM